期刊文献+

80岁以上老年恶性肿瘤患者外周血调节性T细胞检测及其临床意义 被引量:6

Detection and clinical values of CD4^+ CD25^+ regulatory cells in peripheral blood of patients with malignant tumor aged 80 years old and over
下载PDF
导出
摘要 目的探讨检测≥80岁老年恶性肿瘤患者外周血调节性T细胞(Treg)的临床意义。方法应用流式细胞学方法和免疫比浊法分别检测≥80岁健康老年人30例(对照组)及恶性肿瘤患者70例外周血Treg比率和血清C-反应蛋白(CRP)浓度,同时根据国际抗癌协会标准进行临床分期,根据Karnofsky法评定患者功能状态。结果肿瘤组外周Treg比率、血清CRP浓度与对照组比较明显升高,差异具有统计学意义(P均<0.01)。直线相关分析显示,肿瘤组外周血Treg比率与血清CRP浓度、肿瘤TNM临床分期正相关(r=0.416、0.248,P<0.01),与KPS评分负相关(r=-0.438,P<0.01)。结论≥80岁老年恶性肿瘤患者外周血Treg比率明显升高,且与CRP浓度、TNM临床分期及KPS评分具有一定的相关性。检测≥80岁老年恶性肿瘤患者外周血Treg比率有助于判断预后。 Objective To evaluate the change of CD4+CD25+regulatory cells(Treg) in peripheral blood of patients with malignant tumor aged 80 years old and over.Methods Seventy elderly patients with malignant tumor aged 80 and over were enrolled in this study,and 30 healthy aged people were enrolled as controls.The ratio of Treg in the peripheral blood was determined by flow cytometry.Meanwhile,the plasma level of C-reactive protein(CRP) was detected by immunoturbidimetry.Results The ratio of Treg in the peripheral blood and the plasma levels of CRP in very elderly patients with malignant tumor were significantly higher than those in the normal controls(P〈0.01).With the increase of the level of CRP and tumor clinical stage,the ratio of Treg in the peripheral blood increased.There were significant positive correlations between the ratio of Treg in the peripheral blood and the plasma levels of CRP,tumor clinical stage.Reversely,there was a significant negative correlation between the ratio of Treg and Karnofsky score.Conclusions The ratio of Treg in the peripheral blood in very elderly patients with malignant tumor is significantly increased in comparison with that in healthy subjects.It helps determine the prognosis of very elderly patients with malignant tumor by detecting the ratio of Treg in the peripheral blood.
出处 《实用老年医学》 CAS 2011年第6期451-453,共3页 Practical Geriatrics
基金 江苏省卫生厅课题(P200916)
关键词 老年人 恶性肿瘤 调节性T细胞 C-反应蛋白 aged malignant tumor regulatory cells C-reactive protein
  • 相关文献

参考文献15

  • 1第三次全国死因调查主要情况[J].中国肿瘤,2008,17(5):344-345. 被引量:254
  • 2Dejaco C,Duftner C, Schirmer M. Are regulatory T-cells linked with aging? [J]. Exp Gerontol,2006,41(4):339-345. 被引量:1
  • 3Liu H, Leung BP. CD4+ CD25 + regulatory T cells in health and disease[J]. Clin Exp Pharmacol Physiol, 2006, 33(5/6) :519-524. 被引量:1
  • 4Wei WZ, Morris GP, Kong YC. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells [ J ].Cancer Immunol Immunother, 2004, 53 (2): 73-78. 被引量:1
  • 5Salama P, Phillips M, Grieu F, et al. Tumor-infihrating FOXP3 + T regulatory cells show strong prognostic significance in colorectal cancer [ J ]. J Clin Oncol, 2009,27 ( 2 ) : 186 - 192. 被引量:1
  • 6Tzankov A, Meier C, Hirsehmann P, et al. Correlation of high numbers of intra tumoral FOXP3 + regulatory T cells with im- proved survival in germinal center-like diffuse large B-cell lymphoma,follicular lymphoma and classical Hodgkin's lym- phoma [ J ]. Haematologica,2008,93 (2) : 193-200. 被引量:1
  • 7Boucek J, Mrkvan T, Chovanec M, et al. Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck [ J ]. J Cell Mol Med, 2010, 14(1/2) :426-433. 被引量:1
  • 8Karagoz B, Bilgi O, Gumus M, et al. CD8 + CD28-cells and CD4 + CD25 + regulatory T ceils in the peripheral blood of advanced stage lung cancer patients [ J ]. Med Oncol, 2010, 27 (2) : 199-202. 被引量:1
  • 9Koyama K, Kagamu H, Miura S, et al. Reciprocal CD4 + T-cell balance of effector CD62L low CD4 + and CD62L high CD25 + CD4 + regulatory T cells in small cell lung cancer re- flects disease stage[J]. Clin Cancer Res, 2008, 14(21): 6770 -6779. 被引量:1
  • 10Shen LS,Wang J,Shen DF,et al. CD4( + )CD25( + ) CD127 (low/-) regulatory T cells express Foxp3 and suppress effec- tor T cell proliferation and contribute to gastric cancers pro- gression [ J ]. Olin Irnmunol, 2009,131 ( 1 ) : 109-118. 被引量:1

二级参考文献2

共引文献255

同被引文献50

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部